| Margaret A Zeiss, PT | |
|
1403 West Ramshorn, Suite 5, Dubois, WY 82513 | |
| (307) 455-3292 | |
| (307) 455-3339 |
| Full Name | Margaret A Zeiss |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 39 Years |
| Location | 1403 West Ramshorn, Dubois, Wyoming |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386663813 | NPI | - | NPPES |
| 116399000 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT - 747 (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agilitas Usa Inc | 3375454648 | 634 |
News Archive
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer. "It's known as Mnk, and although it appears not to be essential for normal cell maintenance, it's important for cancer growth" said Dr. Luc Furic, a postdoctoral researcher working with Dr. Nahum Sonenberg at McGill University's Goodman Cancer Research Centre and Department of Biochemistry.
Scientists have developed a new web-based tool that may better predict whether a person will suffer a second stroke within 90 days of a first stroke, according to research published in the December 16, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NOAA and the National Science Foundation have awarded $824,225 in competitive funds for the first year of an anticipated four-year $2.8 million project to develop early warning forecast models for toxic harmful algal blooms, or HABs, on Pacific Northwest beaches. Funds were awarded to the University of Washington and the University of California at Santa Cruz through the interagency Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program.
GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20041115000337 |
News Archive
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer. "It's known as Mnk, and although it appears not to be essential for normal cell maintenance, it's important for cancer growth" said Dr. Luc Furic, a postdoctoral researcher working with Dr. Nahum Sonenberg at McGill University's Goodman Cancer Research Centre and Department of Biochemistry.
Scientists have developed a new web-based tool that may better predict whether a person will suffer a second stroke within 90 days of a first stroke, according to research published in the December 16, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NOAA and the National Science Foundation have awarded $824,225 in competitive funds for the first year of an anticipated four-year $2.8 million project to develop early warning forecast models for toxic harmful algal blooms, or HABs, on Pacific Northwest beaches. Funds were awarded to the University of Washington and the University of California at Santa Cruz through the interagency Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program.
GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret A Zeiss, PT Po Box 775, Dubois, WY 82513-0775 Ph: (307) 455-3292 | Margaret A Zeiss, PT 1403 West Ramshorn, Suite 5, Dubois, WY 82513 Ph: (307) 455-3292 |
News Archive
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer. "It's known as Mnk, and although it appears not to be essential for normal cell maintenance, it's important for cancer growth" said Dr. Luc Furic, a postdoctoral researcher working with Dr. Nahum Sonenberg at McGill University's Goodman Cancer Research Centre and Department of Biochemistry.
Scientists have developed a new web-based tool that may better predict whether a person will suffer a second stroke within 90 days of a first stroke, according to research published in the December 16, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NOAA and the National Science Foundation have awarded $824,225 in competitive funds for the first year of an anticipated four-year $2.8 million project to develop early warning forecast models for toxic harmful algal blooms, or HABs, on Pacific Northwest beaches. Funds were awarded to the University of Washington and the University of California at Santa Cruz through the interagency Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program.
GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
William Lemke Physical Therapy P.c. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Ponderosa Ct, 5647 Us Highway 26, Dubois, WY 82513 Phone: 307-455-2236 Fax: 307-455-2250 | |
Mr. William Ervin Lemke, PHYSICAL THERAPIST Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2 Ponderosa Ct, Dubois, WY 82513 Phone: 307-455-2236 Fax: 307-455-2236 |